PHYSICIANS RLTY TR's ticker is DOC and the CUSIP is 71943U104. A total of 347 filers reported holding PHYSICIANS RLTY TR in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,365 | -41.6% | 112 | -32.9% | 0.00% | – |
| Q2 2023 | $2,336 | +39.7% | 167 | +49.1% | 0.00% | – |
| Q1 2023 | $1,672 | -75.5% | 112 | -76.3% | 0.00% | -100.0% |
| Q4 2022 | $6,830 | +241.5% | 472 | +300.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 118 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 118 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 118 | -23.9% | 0.00% | -100.0% |
| Q4 2021 | $3,000 | -40.0% | 155 | -39.7% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 257 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | 0.0% | 257 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -50.0% | 257 | -50.0% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | +100.0% | 514 | +100.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | +66.7% | 257 | +53.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +200.0% | 168 | +194.7% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 57 | +11.8% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| V3 Capital Management, L.P. | 2,490,000 | $43,874,000 | 5.84% |
| HEITMAN REAL ESTATE SECURITIES LLC | 2,649,950 | $46,692,000 | 2.12% |
| Clean Yield Group | 335,615 | $5,914,000 | 1.94% |
| Sapience Investments, LLC | 911,490 | $16,060,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 866,108 | $15,261,000 | 1.77% |
| ISTHMUS PARTNERS, LLC | 468,785 | $8,260,000 | 1.50% |
| Uniplan Investment Counsel, Inc. | 900,057 | $15,859,000 | 0.98% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,712,970 | $30,183,000 | 0.94% |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 1,193,200 | $21,024,000 | 0.76% |
| Oxbow Advisors, LLC | 416,811 | $7,344,000 | 0.75% |